| Acne |
1 |
0.68 |
| Food and Drug Administration (FDA) |
0 |
0.88 |
| Rosacea |
0 |
0.4 |
| California |
0 |
0.39 |
| Isotretinoin |
0 |
0.39 |
| Pregnancy |
0 |
0.26 |
| Dorsum |
0 |
0.2 |
| Adolescent Medicine |
0 |
0.1 |
| New York |
0 |
0.1 |
| Risk Evaluation and Mitigation Strategies |
0 |
0.1 |
| Transgender |
0 |
0.1 |
| Contraception |
0 |
0.09 |
| Patient Safety |
0 |
0.09 |
| Revenue and Practice Management |
0 |
0.09 |
| Skin and Soft Tissue Infection |
0 |
0.09 |
| Social Determinants of Health |
0 |
0.09 |